Medicaloid

Bristol Myers Squibb

Novavax and Commonwealth of Australia announce agreement in principle for acquisition of Novavax COVID-19 vaccine

Medicaloid
Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced the signing of a non-binding Heads of Terms...